Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks

Nov. 21, 2023
A new FDA report.

On November 16, the Food and Drug Administration announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks.

The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts.

MITRE release

ID 109697152 © Leigh_341 | Dreamstime.com
dreamstime_xxl_109697152
JLco - Julia Amaral / iStock / Getty Images Plus / Getty Images
untitled_design_11
ID 167606759 © Pop Nukoonrat | Dreamstime.com
dreamstime_xxl_167606759
ID 252304527 © Yanadee | Dreamstime.com
dreamstime_xxl_252304527